Clinical Trials Logo

Reflux Laryngitis clinical trials

View clinical trials related to Reflux Laryngitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT01755221 Unknown status - Clinical trials for Laryngopharyngeal Reflux (LPR)

Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR

Start date: August 2012
Phase: N/A
Study type: Interventional

The purpose of this research study is to better understand whether information obtained from a pH probe can help physicians predict whether a patient will respond to the medication that is prescribed for laryngopharyngeal reflux (LPR). The current treatment given to individuals who are diagnosed with LPR is a course of proton pump inhibitor (PPI) medication. Subjects who agree to participate in this study will have a small flexible tube (about the width of a piece of cooked spaghetti) placed in their throat. This tube measures the pH in the throat over a period of 24 hours and helps physicians study the relationship between pH level, LPR symptoms, and the effectiveness of PPI therapy. This study may help physicians find out if certain symptoms or characteristics can help them predict if the PPI medication will be effective for each patient. After probe removal, subjects will receive compensation. They will return to the clinic at their regularly scheduled follow-up visit with the physician, 8 to 12 weeks after starting the PPI medication. At that time, subjects can choose to participate in an optional probe placement.